Nkgen BiotechNKGN
13F holders, Q3 2025 (September 30)1holders −2
1new positions
0sold out
$0.11avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Nkgen Biotech Inc. (NKGN) in their 13F filings, down 2 from Q1 2025. 1 opened new positions and 0 sold out. The largest holder was Meteora Capital, LLC ($303K).
- Company
- Nkgen Biotech Inc.
- CUSIP
- 65488A101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $303K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q3 2025: 2,755,935 shares bought, net +2,755,935 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Meteora Capital, LLC | 0.03% | New | 2,755,935 | $303K |
"% of holder's portfolio" is NKGN's weight in each manager's 13F, not the share of Nkgen Biotech Inc. the manager owns.